Nicole Woldmar

Rio De Janeiro, RJ 21941909, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

AI-based digital pathology and spatial proteomics enable precision oncology: A case report of recurrent melanoma in a young patient.

AI-based digital pathology and spatial proteomics enable precision oncology: A case report of recurrent melanoma in a young patient.

Journal: NPJ precision oncology
Published: October 20, 2025

Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT.

Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT.

Journal: Journal of proteome research
Published: May 05, 2025

A perspective on integrating digital pathology, proteomics, clinical data and AI analytics in cancer research.

A perspective on integrating digital pathology, proteomics, clinical data and AI analytics in cancer research.

Journal: Journal of proteomics
Published: February 19, 2025

The melanoma MEGA-study: Integrating proteogenomics, digital pathology, and AI-analytics for precision oncology.

The melanoma MEGA-study: Integrating proteogenomics, digital pathology, and AI-analytics for precision oncology.

Journal: Journal of proteomics
Published: February 03, 2025

Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes.

Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes.

Journal: International journal of dermatology
Published: October 02, 2024

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.

Journal: bioRxiv : the preprint server for biology
Published: May 15, 2024

Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.

Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.

Journal: Clinical and translational medicine
Published: May 07, 2024

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.

Journal: Frontiers in oncology
Published: May 05, 2024

Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction.

Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction.

Journal: bioRxiv : the preprint server for biology
Published: March 28, 2024

Mitochondrial and immune response dysregulation in melanoma recurrence.

Mitochondrial and immune response dysregulation in melanoma recurrence.

Journal: Clinical and translational medicine
Published: September 29, 2023

In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer.

In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer.

Journal: Clinical and translational medicine
Published: May 26, 2022

Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases.

Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases.

Journal: ESMO open
Published: May 25, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026